Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $7,500 · Income ≤500% FPL · Covers drug cost only — administration billed separately
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C50 C50.0 C50.1 C50.2 C50.3 C50.4 C50.5 C50.6 C50.8 C50.9 C80.0 C80.1 D05 D05.0 D05.1 D05.9Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J1100 J1740 J2430 J3487 J3489 J9023
The foundation's own covered-medication list for this fund (224 drugs). Confirm coverage of your exact NDC at application.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 800-675-8416, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Prolia / Jubbonti + biosimilars, Tecentriq, Avastin / biosimilars, Imfinzi.
Status shown as of each fund's last verification.
As of June 11, 2026, the HealthWell Foundation Breast Cancer fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 800-675-8416.
Up to $7,500. Covers drug cost only — administration billed separately
Household income must be ≤500% FPL. US resident.
Accepted: commercial, medicare. Not eligible: medicaid.
The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.